Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS1033 on Diabetes Mellitus
NCT07684625Phase 4Completed
- Sponsor
- Universitas Sebelas Maret
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
A Phase 4 trial of DLBS1033 in type 2 diabetes mellitus (T2DM), sponsored by Universitas Sebelas Maret. Started Mar 2026; status: completed.
02
Drugs
DLBS1033
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07684625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07684625.